Cost Of Sales Zmiana Data
AbbVie USD 4.28B 90M 2023-12
Agios Pharmaceuticals USD 586K 47K 2023-12
Alnylam Pharmaceuticals USD 85.86M 1.55M 2023-12
Amgen USD 3.11B 1.31B 2023-12
Astellas Pharma JPY 74.41B 5.47B 2023-09
AstraZeneca USD 2.06B 91M 2023-09
Bayer EUR 4.81B 94M 2023-09
Biogen USD 618.3M 41.3M 2023-12
BioMarin Pharmaceutical USD 135.48M 10.73M 2023-12
Bluebird Bio USD 10.96M 1.39M 2023-09
Bristol-Myers Squibb USD 2.71B 217M 2023-12
Daiichi Sankyo JPY 94.74B 1.06B 2023-09
Eli Lilly USD 1.79B 72.1M 2023-12
Exelixis USD 18.77M 1.07M 2023-09
Gilead Sciences USD 1.61B 46M 2023-12
GlaxoSmithKline GBP 2.24B 343M 2023-09
Incyte USD 64.05M 9.66M 2023-12
Ionis Pharmaceuticals USD 3.06M 871K 2023-12
Merck USD 3.34B 891M 2023-12
Moderna USD 929M 1.31B 2023-12
Nektar Therapeutics USD 12.43M 5.44M 2023-09
Pfizer USD 6.66B 2.24B 2023-12
Regeneron Pharmaceuticals USD 517M 80.6M 2023-12
Roche Holding CHF 7.62B 1.33B 2023-06
Sarepta Therapeutics USD 37.03M 2.9M 2023-09
Vertex Pharmaceuticals USD 318.7M 10.1M 2023-09



Agios Pharmaceuticals Koszty Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.